JGVRX
Price
$42.60
Change
-$0.48 (-1.11%)
Updated
Jun 13 closing price
Net Assets
21.42B
VIGRX
Price
$215.38
Change
-$2.91 (-1.33%)
Updated
Jun 13 closing price
Net Assets
293.94B
Interact to see
Advertisement

JGVRX vs VIGRX

Header iconJGVRX vs VIGRX Comparison
Open Charts JGVRX vs VIGRXBanner chart's image
JPMorgan Growth Advantage R5
Price$42.60
Change-$0.48 (-1.11%)
VolumeN/A
Net Assets21.42B
Vanguard Growth Index Investor
Price$215.38
Change-$2.91 (-1.33%)
VolumeN/A
Net Assets293.94B
JGVRX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JGVRX vs. VIGRX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGVRX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 294B vs. JGVRX (21.4B). VIGRX pays higher dividends than JGVRX: VIGRX (0.35) vs JGVRX (0.00). JGVRX was incepted earlier than VIGRX: JGVRX (16 years) vs VIGRX (33 years). JGVRX (0.68) is less costly to investors than VIGRX (0.17). JGVRX is a more actively managed with annual turnover of: 28.00 vs. VIGRX (11.00). JGVRX has a lower initial minimum investment than VIGRX: JGVRX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 12.60 vs. JGVRX (7.55). VIGRX return over 5 years is better than : 115.22 vs. JGVRX (67.06).
JGVRXVIGRXJGVRX / VIGRX
Total Expense Ratio0.600.17353%
Annual Report Gross Expense Ratio0.680.17400%
Fund Existence16 years33 years-
Gain YTD1.6461.93685%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets21.4B294B7%
Annual Yield % from dividends0.000.35-
Returns for 1 year7.5512.6060%
Returns for 3 years75.6091.6482%
Returns for 5 years67.06115.2258%
Returns for 10 years160.69286.5456%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSTL18.75-0.07
-0.37%
Castle Biosciences
KAVL0.53-0.01
-1.67%
Kaival Brands Innovations Group
INCY67.75-1.47
-2.12%
Incyte Corp
FLG11.04-0.36
-3.16%
Flagstar Financial Inc
TARA3.14-0.12
-3.68%
Protara Therapeutics